Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

NCT01511848 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Beta-thalassemia Major
Sickle Cell Disease
Iron Hemosiderosis

Interventions

DRUG: DFP (ferriprox) and deferasirox (ICL 670)
DRUG: DFP, DFO

Sponsor

Ain Shams University